Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5976)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2014 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang XL, Shi HJ, Wang JP, Tang HS, Wu YB, Fang ZY, Cui SZ, Wang LT. MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin. World J Gastroenterol 2014; 20(32): 11347-11355 [PMID: 25170221 DOI: 10.3748/wjg.v20.i32.11347] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i32/11347.htm |
| Number | Citing Articles |
| 1 |
Peng Peng, Tao Chen, Qing Wang, Yixi Zhang, Fangfang Zheng, Shuai Huang, Yubo Tang, Chunxiao Yang, Wenqing Ding, Dong Ren, Zongwen Huang, Yuanqing Guo. Decreased miR-218–5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer. Oncology Research and Treatment 2019; 42(4): 165 doi: 10.1159/000495473
|
| 2 |
Ya-Kai Huang, Jian-Chun Yu. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. World Journal of Gastroenterology 2015; 21(34): 9863-9886 doi: 10.3748/wjg.v21.i34.9863
|
| 3 |
Akiharu Kimura, Kyoichi Ogata, Bolag Altan, Takehiko Yokobori, Erito Mochiki, Mitsuhiro Yanai, Norimichi Kogure, Toru Yanoma, Masaki Suzuki, Tuya Bai, Hiroyuki Kuwano. Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis. World Journal of Gastroenterology 2017; 23(42): 7541-7550 doi: 10.3748/wjg.v23.i42.7541
|
| 4 |
Mengyan Xie, Ling Ma, Tongpeng Xu, Yutian Pan, Qiang Wang, Yutian Wei, Yongqian Shu. Potential Regulatory Roles of MicroRNAs and Long Noncoding RNAs in Anticancer Therapies. Molecular Therapy - Nucleic Acids 2018; 13: 233 doi: 10.1016/j.omtn.2018.08.019
|
| 5 |
Keiji Nishibeppu, Shuhei Komatsu, Taisuke Imamura, Jun Kiuchi, Takuma Kishimoto, Tomohiro Arita, Toshiyuki Kosuga, Hirotaka Konishi, Takeshi Kubota, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Eigo Otsuji. Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59939-8
|
| 6 |
Ya-Jun Luo, Qing-Mei Huang, Yan Ren, Zi-Lin Liu, Cheng-Fei Xu, Hao Wang, Jiang-Wei Xiao. Non-coding RNA in drug resistance of gastric cancer. World Journal of Gastrointestinal Oncology 2019; 11(11): 957-970 doi: 10.4251/wjgo.v11.i11.957
|
| 7 |
Mitsuro Kanda, Yasuhiro Kodera. Molecular mechanisms of peritoneal dissemination in gastric cancer. World Journal of Gastroenterology 2016; 22(30): 6829-6840 doi: 10.3748/wjg.v22.i30.6829
|
| 8 |
Tianxi Wang, Jun Zhang, Jingjing Tian, Shasha Hu, Rongna Wei, Lihong Cui. Low expression levels of plasma miR‑141 are associated with susceptibility to gastric cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10390
|
| 9 |
Arash Poursheikhani, Zahra Bahmanpour, Ehsan Razmara, Ladan Mashouri, Mohammad Taheri, Dorsa Morshedi Rad, Hassan Yousefi, Amirreza Bitaraf, Sadegh Babashah. Non-coding RNAs underlying chemoresistance in gastric cancer. Cellular Oncology 2020; 43(6): 961 doi: 10.1007/s13402-020-00528-2
|
| 10 |
Lin Jingjing, Wang Wangyue, Xu Qiaoqiao, Ye Jietong. MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression. Open Medicine 2016; 11(1): 31 doi: 10.1515/med-2016-0007
|
| 11 |
Ying Hu, Ruitong Xu, Jinxia Ma, Zhanpeng Yan, Jun Ma. Curcumol enhances cisplatin sensitivity of gastric cancer: involvement of microRNA-7 and the nuclear factor-kappa B/snail family transcriptional repressor 1 axis. Bioengineered 2022; 13(5): 11667 doi: 10.1080/21655979.2022.2070975
|
| 12 |
Lisi Zeng, Quanxing Liao, Xiaohui Zeng, Jiacai Ye, Xianzi Yang, Siyu Zhu, Hongsheng Tang, Gaojie Liu, Weiwen Cui, Shaohua Ma, Shuzhong Cui. Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer. Bioengineered 2022; 13(2): 2623 doi: 10.1080/21655979.2021.2021348
|
| 13 |
Qiang Ruan, Zhi-yuan Fang, Shu-zhong Cui, Xiang-liang Zhang, Yin-bing Wu, Hong-sheng Tang, Yi-nuo Tu, Yan Ding. Thermo-chemotherapy Induced miR-218 upregulation inhibits the invasion of gastric cancer via targeting Gli2 and E-cadherin. Tumor Biology 2015; 36(8): 5807 doi: 10.1007/s13277-015-3250-4
|
| 14 |
Ying-fei Lu, Li Zhang, Mary Miu Yee Waye, Wei-ming Fu, Jin-fang Zhang. MiR-218 Mediates tumorigenesis and metastasis: Perspectives and implications. Experimental Cell Research 2015; 334(1): 173 doi: 10.1016/j.yexcr.2015.03.027
|
| 15 |
Jianning Song, Jie Yin, Zhigang Bai, Jun Zhang, Hua Meng, Jun Cai, Wei Deng, Xuemei Ma, Zhongtao Zhang. The Profile of Serum microRNAs Predicts Prognosis for Resected Gastric Cancer Patients Receiving Platinum-Based Chemotherapy. Digestive Diseases and Sciences 2017; 62(5): 1223 doi: 10.1007/s10620-017-4513-2
|
| 16 |
Chunhui Lang, Miao Xu, Ziyi Zhao, Jinyao Chen, Lishi Zhang. MicroRNA‑96 expression induced by low‑dose cisplatin or doxorubicin regulates chemosensitivity, cell death and proliferation in gastric cancer SGC7901 cells by targeting FOXO1. Oncology Letters 2018; doi: 10.3892/ol.2018.9122
|
| 17 |
Yunhui Hu, Kun Xu, Ernesto Yagüe. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer. Breast Cancer Research and Treatment 2015; 151(2): 269 doi: 10.1007/s10549-015-3372-9
|
| 18 |
Zhixian Lin, Jiangfeng Chen, Yunxia Liu. The efficacy of traditional chinese medicine combined with hyperthermic intraperitoneal chemotherapy for malignant ascites: A systematic review and meta-analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.938472
|
| 19 |
Vaidotas Cesna, Arturas Sukovas, Aldona Jasukaitiene, Rima Naginiene, Giedrius Barauskas, Zilvinas Dambrauskas, Saulius Paskauskas, Antanas Gulbinas. Narrow line between benefit and harm: Additivity of hyperthermia to cisplatin cytotoxicity in different gastrointestinal cancer cells. World Journal of Gastroenterology 2018; 24(10): 1072-1083 doi: 10.3748/wjg.v24.i10.1072
|
| 20 |
Prakash C. Sharma, Renu Verma. Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 73 doi: 10.1007/978-981-15-4431-6_6
|
| 21 |
Ling Wei, Jujie Sun, Nasha Zhang, Yan Zheng, Xingwu Wang, Liyan Lv, Jiandong Liu, Yeyang Xu, Yue Shen, Ming Yang. Noncoding RNAs in gastric cancer: implications for drug resistance. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01185-7
|
| 22 |
Luis Alejandro Arias Sosa, Bibiana Matilde Bernal Gómez, Andrés Felipe Cuspoca Orduz. Supresión tumoral por microARN en el cáncer gástrico. Gaceta Mexicana de Oncología 2016; 15(4): 222 doi: 10.1016/j.gamo.2016.07.003
|
| 23 |
Jula Veerapong, Andrew M. Lowy. Cancer Regional Therapy. 2020; : 83 doi: 10.1007/978-3-030-28891-4_7
|
| 24 |
Changqing Liu, Shan Li, Yunlian Tang. Mechanism of cisplatin resistance in gastric cancer and associated microRNAs. Cancer Chemotherapy and Pharmacology 2023; 92(5): 329 doi: 10.1007/s00280-023-04572-1
|
| 25 |
Lijun Chen, Dongfang Yuan, Yichen Yang, Minzhu Ren. LincRNA‐p21 enhances the sensitivity of radiotherapy for gastric cancer by targeting the β‐catenin signaling pathway. Journal of Cellular Biochemistry 2019; 120(4): 6178 doi: 10.1002/jcb.27905
|
| 26 |
Mehrdad Hashemi, Sadaf Gholami, Rasoul Raesi, Sareh Sarhangi, Behnaz Mahmoodieh, Zeinab Khazaei Koohpar, Mohammad Ali Sheikh Beig Goharrizi, Mitra Behroozaghdam, Maliheh Entezari, Shokooh Salimimoghadam, Wenliang Zha, Mohsen Rashidi, Soheila Abdi, Afshin Taheriazam, Noushin Nabavi. Biological and therapeutic viewpoints towards role of miR-218 in human cancers: Revisiting molecular interactions and future clinical translations. Cellular Signalling 2023; 109: 110786 doi: 10.1016/j.cellsig.2023.110786
|
| 27 |
Xiaoqi Zeng, Huijuan Shi, Jiping Wang, Shuzhong Cui, Hongsheng Tang, Xiangliang Zhang. Long noncoding RNA aberrant expression profiles after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of AGC ascertained by microarray analysis. Tumor Biology 2015; 36(7): 5021 doi: 10.1007/s13277-015-3153-4
|
| 28 |
Wanli Yang, Jiaojiao Ma, Wei Zhou, Bo Cao, Xin Zhou, Zhiping Yang, Hongwei Zhang, Qingchuan Zhao, Daiming Fan, Liu Hong. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Expert Opinion on Therapeutic Targets 2017; 21(11): 1063 doi: 10.1080/14728222.2017.1389900
|
| 29 |
Jinxin Feng, Kejun Li, Gaojie Liu, Yanlin Feng, Huijuan Shi, Xiangliang Zhang. Precision hyperthermia-induced miRNA-409–3p upregulation inhibits migration, invasion, and EMT of gastric cancer cells by targeting KLF17. Biochemical and Biophysical Research Communications 2021; 549: 113 doi: 10.1016/j.bbrc.2021.02.063
|
| 30 |
Thalia Erbes, Marc Hirschfeld, Silvia Waldeck, Gerta Rücker, Markus Jäger, Lucas Willmann, Bernd Kammerer, Sebastian Mayer, Gerald Gitsch, Elmar Stickeler. Hyperthermia-driven aberrations of secreted microRNAs in breast cancer in vitro. International Journal of Hyperthermia 2016; 32(6): 630 doi: 10.3109/02656736.2016.1161832
|
| 31 |
Chao Chen, Xiaohuan Tang, Yuanda Liu, Jiaming Zhu, Jingjing Liu. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review). International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4751
|
| 32 |
Yanshan Zhang, Weizuo Chen, Huijuan Wang, Tingting Pan, Yinguo Zhang, Chao Li. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway. Cancer Chemotherapy and Pharmacology 2019; 84(6): 1209 doi: 10.1007/s00280-019-03922-2
|
| 33 |
Alireza Ahadi. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression. IUBMB Life 2020; 72(5): 884 doi: 10.1002/iub.2259
|
| 34 |
Jie Du, Mingliang Li, Qiong Huang, Wanli Liu, Wen-qun Li, Yuan-jian Li, Zhi-cheng Gong. The critical role of microRNAs in stress response: Therapeutic prospect and limitation. Pharmacological Research 2019; 142: 294 doi: 10.1016/j.phrs.2018.12.007
|
| 35 |
Qing Yang, Ren-Wen Zhang, Peng-Cheng Sui, Hai-Tao He, Lei Ding. Dysregulation of non-coding RNAs in gastric cancer. World Journal of Gastroenterology 2015; 21(39): 10956-10981 doi: 10.3748/wjg.v21.i39.10956
|
| 36 |
Yong-Ping Mu, Wen-Jie Sun, Chuan-Wen Lu, Xiu-Lan Su. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer. Asian Pacific Journal of Cancer Prevention 2015; 16(12): 4813 doi: 10.7314/APJCP.2015.16.12.4813
|
| 37 |
Yiwen Wu, Xiaoyan Yang, Zhizhong Xie, Haihong Hu, Xiaoyong Lei, Dun Niu, Shiyan Li, Lu Tuo. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer. Combinatorial Chemistry & High Throughput Screening 2022; 25(13): 2127 doi: 10.2174/1386207325666220401090604
|